Last quarter (Q3 2024), Elevance Health's total revenue was $45.11B, an increase of 5.27% from the same quarter last year. In Q3, Elevance Health's net income was $1.02B. See Elevance Health’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 174.22B	$ 171.34B	$ 156.59B	$ 138.64B	$ 121.87B	$ 104.21B
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Income	$ 3.83B	$ -11.04B	$ -6.83B	$ -5.05B	$ -4.33B	$ ―
Net Non Operating Interest Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Other Income Expense	$ 19.25B	$ 19.45B	$ 14.98B	$ -2.00M	$ -10.38B	$ -2.76B
Pretax Income	$ 8.30B	$ 7.71B	$ 7.60B	$ 7.92B	$ 6.24B	$ 5.99B
Tax Provision	$ 1.91B	$ 1.72B	$ 1.71B	$ 1.85B	$ 1.67B	$ 1.18B
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ 6.42B	$ 5.99B	$ 5.89B	$ 6.16B	$ 4.57B	$ 4.81B
Basic EPS	$ 27.64	$ 25.38	$ 25.10	$ 25.04	$ 18.23	$ 18.81
Diluted EPS	$ 27.48	$ 25.22	$ 24.81	$ 24.73	$ 17.98	$ 18.47
Basic Average Shares	$ 931.00M	$ 235.90M	$ 240.00M	$ 243.80M	$ 250.80M	$ 255.50M
Diluted Average Shares	$ 936.30M	$ 237.40M	$ 242.80M	$ 246.80M	$ 254.30M	$ 260.30M
Dividend Per Share	$ 6.37	$ 5.92	$ 5.92	$ 5.12	$ 4.52	$ 3.20
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ -165.92B	$ -163.63B	$ -149.00B	$ -130.71B	$ -115.63B	$ -98.23B
Net Income From Continuing And Discontinued Operation	$ 6.42B	$ 5.99B	$ 5.89B	$ 6.16B	$ 4.57B	$ 4.81B
Normalized Income	$ 8.27B	$ 6.55B	$ 6.04B	$ ―	$ ―	$ 4.74B
Interest Expense	$ 1.10B	$ 1.03B	$ 851.00M	$ 798.00M	$ 784.00M	$ 746.00M
EBIT	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBITDA	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―

Currency in USD

Elevance Health Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing